86 million (or 53%), increasing in services of THB 11 million (or 47%) from Q2/2017, increasing in revenue from sales mainly came from Distributor of medical devices and equipment. The Company and its
the interim financial information, the Company has reviewed and changed the estimated useful lives of buildings, machinery and equipment in accordance with their conditions and the proper estimation of
recognition WCIH as subsidiary company. 3 2. Financial Performance Summary – by business Revenues by business Baht’000 Consolidated 2019 2018 ∆% Distributor of medical devices and equipment 1,736,795 1,828,053
1,417.3 153.8 9.4 377.5 26.6 Rental income from equipment for lease 69.7 55.2 58.1 14.5 26.3 11.6 20.0 Cost of sales and service 1,436.4 1,366.0 1,203.1 70.4 5.2 233.3 19.4 Selling and distribution expenses
Baht 26.44 million from mutual fund and private fund managements fee from Solaris Asset Management Company Limited (Solaris) decreased. Gain and return on financial instruments decreased of Baht 22.50
and return on financial instruments decreased of Baht 22.50 million from gain from investment in securities decreased of Baht 21.79 million due to loss from investment in equity securities increased of
company will be set up a wholly- owned of the Listed Subsidiary 2. The Construction of Wattanapat Samui Hospital Building Contractor : N/A 3. Buying the Medical Instruments The Company will appropriately
company will be set up a wholly-owned of the Listed Subsidiary 2. The Construction of Wattanapat Samui Hospital Building Contractor : N/A 3. Buying the Medical Instruments The Company will appropriately
Dealing Which is Not Limited to Debt Instruments or Investment Units dated 3 August 2009, and Clause 6, Paragraph 1 of Clause 8 and Clause 33 of the Notification of the Capital Market Supervisory Board No